Healthcare Contract Research Outsourcing Market - Global Scenario, Market Size, Outlook, Trend and Forecast, 2016 - 2025

Global Healthcare Contract Research Outsourcing Market is estimated to reach $58.9 billion by 2025; growing at a CAGR of 6.9% from 2017 to 2025. Healthcare contract research outsourcing offers support to the medical device, biotechnology, and pharmaceutical industries in the form of research services outsourced. Healthcare contract research outsourcing services includes clinical research commercialization, biologic assay development, clinical trials management, biopharmaceutical development, pharmacovigilance, and preclinical research, among others. Healthcare companies normally outsource drug development functions to contract research organizations to competently use the development capabilities globally. The therapeutic, clinical, and regulatory expertise of CROs help to enhance the whole rate of development as well as fast-track time to market for a new product.

Major factors driving the global healthcare contract research outsourcing market are increase in number of clinical trials, growing outsourcing activities to save cost & time, and growing R&D expenditure. However, strong competition in the CRO services market may hamper the market growth. Furthermore, growth in demand for specialized testing services would unfold with numerous growth opportunities in the forecasted year.

Major segments of the global healthcare contract research outsourcing market are service, therapeutic area, end user, and geography. The service segment comprises regulatory service, medical writing, pharmacovigilance, site management protocol, clinical trial service, clinical data management & biometrics and other services. Therapeutic area contains respiratory, infectious diseases, oncology/hematology, immunology, rare diseases, CNS, CV/metabolic, medical devices and other therapeutic area. Further, market is bifurcated by end use into biotechnology companies, medical device companies, pharmaceutical companies and academic institutes & government organizations.

Geographically, the global healthcare contract research outsourcing market is categorized into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America is further bifurcated into U.S., Canada, and Mexico whereas Europe segment consist of UK, Russia, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into China, Japan, South Korea, India, and Rest of Asia-Pacific while RoW is bifurcated into South America, Middle East, and Africa.

The major players competing in the market are Pharmaceutical Product Development, LLC, Charles River, Laboratory Corporation of America Holdings, IQVIA, Medpace, Syneos Health, PAREXEL International Corporation, Envigo, ICON plc, and PRA Health Sciences, among others.

The key takeaways from the report
The report will provide detailed analysis of Global Healthcare Contract Research Outsourcing Market with respect to major segments such as service, therapeutic area, and end user
The report will include the qualitative and quantitative analysis with market estimation over 2016 - 2025 and compound annual growth rate (CAGR) between 2017 and 2025
Comprehensive analysis of market dynamics including factors and opportunities will be provided in the report
An exhaustive regional analysis of Global Healthcare Contract Research Outsourcing Market has been included in the report
Profile of the key players in the Global Healthcare Contract Research Outsourcing Market will be provided, which include key financials, product & services, new developments and business strategies
Scope of the Global Healthcare Contract Research Outsourcing Market
Service Segments

Regulatory Service
Medical Writing
Pharmacovigilance
Site Management Protocol
Clinical Trial Service
Clinical Data Management & Biometrics
Other Services
Therapeutic Area Segments

Respiratory
Infectious Diseases
Oncology/Hematology
Immunology
Rare Diseases
CNS
CV/Metabolic
Medical Devices
Other Therapeutic Areas
End User Segments

Biotechnology Companies
Medical Device Companies
Pharmaceutical Companies
academic institutes & government organizations
Geographical Segments

North America
U.S.
Canada
Mexico
Europe
UK
Russia
Germany
France
Italy
Rest of Europe
Asia-Pacific
India
China
Japan
South Korea
Rest of Asia-Pacific
RoW
South America
Middle East
Africa

Geography Analysis:

The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

• North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
• Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
• Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
• Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
• Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.